Innate immunity SNPs are associated with risk for severe sepsis after burn injury

Clin Med Res. 2006 Dec;4(4):250-5. doi: 10.3121/cmr.4.4.250.

Abstract

Objective: To analyze allelic association with clinical outcome in a cohort of burn patients.

Patients: Two hundred twenty-eight individuals with burns > or =15% total body surface area without significant non-burn related trauma who survived >48 hours post-admission were enrolled. One hundred fifty-nine of these patients were analyzed previously.

Methods: Candidate polymorphisms within interleukin-1 beta (IL-1beta), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-alpha), cellular differentiation marker 14 (CD14) and toll-like receptor 4 (TLR4) were evaluated by logistic regression analysis for association with increased risk for severe sepsis (sepsis plus organ dysfunction or shock).

Results: After adjustment for age, burn size, ethnicity, gender and inhalation injury, alleles at TNF-alpha (308G, p=0.013), TLR4 (+896G, p=0.027), IL-6 (174C, p=0.040) and CD14 (159C, p=0.047) were significantly associated with an increased risk for severe sepsis.

Conclusions: Carriage of variant alleles at immune response genes were associated with increased risk for severe sepsis after burn injury.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Alleles*
  • Burns / complications
  • Burns / genetics*
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Immunity, Innate / genetics*
  • Interleukin-1beta / genetics
  • Interleukin-6 / genetics
  • Lipopolysaccharide Receptors / genetics
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Retrospective Studies
  • Risk Factors
  • Sepsis / etiology
  • Sepsis / genetics*
  • Severity of Illness Index
  • Toll-Like Receptor 4 / genetics
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • Interleukin-1beta
  • Interleukin-6
  • Lipopolysaccharide Receptors
  • TLR4 protein, human
  • Toll-Like Receptor 4
  • Tumor Necrosis Factor-alpha